User: Guest  Login
Title:

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.

Document type:
journal article
Author(s):
EVOLVE Trial Investigators; Chertow, GM; Block, GA; Correa-Rotter, R; Drüeke, TB; Floege, J; Goodman, WG; Herzog, CA; Kubo, Y; London, GM; Mahaffey, KW; Mix, TC; Moe, SM; Trotman, ML; Wheeler, DC; Parfrey, PS; Chertow, G; Parfrey, P; Block, G; Correa-Rotter, R; Drüeke, T; Floege, J; Goodman, W; Herzog, C; London, G; Mahaffey, K; Moe, S; Wheeler, D; Hennekens, C; Baigent, C; Brown, W; O'Brien, P; Anderson, S; Hoel, J; Mahaffey, K; Szczech, L; Patel, U; Wampole, J; Pun, P; Felker, M; Inrig, J; Sha...     »
Abstract:
Disorders of mineral metabolism, including secondary hyperparathyroidism, are thought to contribute to extraskeletal (including vascular) calcification among patients with chronic kidney disease. It has been hypothesized that treatment with the calcimimetic agent cinacalcet might reduce the risk of death or nonfatal cardiovascular events in such patients.In this clinical trial, we randomly assigned 3883 patients with moderate-to-severe secondary hyperparathyroidism (median level of intact parath...     »
Journal title abbreviation:
N Engl J Med
Year:
2012
Journal volume:
367
Journal issue:
26
Pages contribution:
2482-94
Language:
eng
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/23121374
Print-ISSN:
0028-4793
TUM Institution:
Abteilung für Nephrologie
 BibTeX